Christopher Cano

Christopher Cano

Oprichter bij
C2 Strategic LLC
55 jaar
Health Technology
Consumer Services
Commercial Services

Profiel

Christopher Cano has founded C2 Strategic LLC in 2011, where he is currently the Managing Partner.
He has held former positions at Noven Pharmaceuticals, Inc., Barrier Therapeutics, Inc., Agile Therapeutics, Inc., Almirall LLC, Nucryst Pharmaceuticals Corp.
(New Jersey), Liberty Medical LLC, TFF Pharmaceuticals, Inc., and Duchesnay USA, Inc. At TFF Pharmaceuticals, Inc., he was the Vice President-Business Development from 2018 to 2020.
Mr. Cano has a graduate degree from Rider University and an undergraduate degree from Villanova University.

Actieve functies van Christopher Cano

BedrijvenFunctieBegin
C2 Strategic LLC
Oprichter 01-01-2011

Eerdere bekende functies van Christopher Cano

BedrijvenFunctieEinde
TFF PHARMACEUTICALS, INC. Operationeel Directeur 18-12-2023
Corporate Officer/Principal -
Corporate Officer/Principal -
Corporate Officer/Principal -
AGILE THERAPEUTICS, INC. Corporate Officer/Principal -
Ervaring van Christopher Cano in detail bekijken

Opleiding van Christopher Cano

Ervaring
Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Verwante bedrijven

Bedrijven in privébezit11

Commercial Services

Health Technology

Health Technology

Health Technology

Consumer Services

Consumer Services

Health Technology

Retail Trade

Health Technology

Health Technology

C2 Strategic LLC

  1. Beurs
  2. Insiders
  3. Christopher Cano